General anaesthesia

Visiongain Publishes Global Inhalation Anaesthesia Market 2019-2029 Report

Retrieved on: 
Wednesday, December 11, 2019

IA has lower risk of delirium and is cost effective compared to IVA

Key Points: 
  • IA has lower risk of delirium and is cost effective compared to IVA
    Inhalational anesthesia used for sedation as well as for the induction and maintenance of general anesthesia.
  • To address the environmental impact of anesthetic gases, new technologies are being developed to scavenge them from hospital vents and recycle them.
  • These anesthetic gases contribute up to 1.0% of global carbon dioxide emissions, leading to greater environmental damage.
  • The inhalation anesthesia market is segmented on the product type, application, and geography.

OMS Logistics, a Mobile Oral Surgery Service Platform, Doubles Footprint in Less than 12 Months

Retrieved on: 
Tuesday, November 26, 2019

Recruiting a stand-alone surgeon requires the development of a very complex infrastructure to ensure patient safety in a dental office.

Key Points: 
  • Recruiting a stand-alone surgeon requires the development of a very complex infrastructure to ensure patient safety in a dental office.
  • National patient safety organizations and State Dental Boards continue to develop more regulations that are rapidly approaching those adopted in Ambulatory Surgery Centers (ASC's).
  • OMS Logistics (OMSL) has developed a mobile delivery system to add surgical services and general anesthesia to the dental environment.
  • Young children and medically complex patients are identified before the day of surgery and triaged to an alternate site of service for their conditions.

Study Uses Masimo Patient SafetyNet™ and rainbow Acoustic Monitoring® to Investigate the Incidence of Desaturation and Bradypnea in Postoperative Patients

Retrieved on: 
Thursday, November 21, 2019

RAM with RRa uses an acoustic transducer positioned on the patients neck to provide noninvasive, continuous respiration monitoring.

Key Points: 
  • RAM with RRa uses an acoustic transducer positioned on the patients neck to provide noninvasive, continuous respiration monitoring.
  • Hypothesizing that postoperative desaturation and bradypnea might occur even in non-ICU patients without serious complications, and in patients who did not undergo major surgery, Drs.
  • Age and postoperative opioid administration were significant risk factors for the combination of desaturation and bradypnea.
  • Ishikawa M and Sakamoto A. Postoperative desaturation and bradypnea after general anesthesia in non-ICU patients: a retrospective evaluation.

Dr. Aaron Quitmeyer Pairs Oral Surgery with Calming Sedation Dentistry in Harrisonburg, VA

Retrieved on: 
Wednesday, October 23, 2019

HARRISONBURG, Va., Oct. 23, 2019 /PRNewswire-PRWeb/ -- Board-certified oral surgeon , Dr. Aaron Quitmeyer, helps patients ease dental anxiety and fear with custom sedation dentistry at his Harrisonburg, VA practice.

Key Points: 
  • HARRISONBURG, Va., Oct. 23, 2019 /PRNewswire-PRWeb/ -- Board-certified oral surgeon , Dr. Aaron Quitmeyer, helps patients ease dental anxiety and fear with custom sedation dentistry at his Harrisonburg, VA practice.
  • In these circumstances, sedation dentistry plays a key role in helping patients feel calm and comfortable enough to receive treatment.
  • Dr. Quitmeyer offers a comprehensive range of sedation dentistry services at his practice, Shenandoah Oral and Facial Surgery, including nitrous oxide, oral sedation, IV sedation, and general anesthesia.
  • Patients with anxiety or phobia about undergoing dental surgery can benefit from sedation dentistry at Dr. Quitmeyer's Harrisonburg, VA practice.

Xavant Technology Announces First Dual-Sensor Neuromuscular Patient Monitor

Retrieved on: 
Tuesday, October 15, 2019

PRETORIA, South Africa, Oct. 15, 2019 /PRNewswire/ --Xavant Technology, a pioneer in neuromuscular monitoring, stimulation, and innovative neuromodulation modalities, announced an addition to the company's newest generation of Stimpod neuromuscular transmission monitor - the capability of utilizing either of the two most industry-prominent types of monitoring sensors: AMG and EMG.

Key Points: 
  • PRETORIA, South Africa, Oct. 15, 2019 /PRNewswire/ --Xavant Technology, a pioneer in neuromuscular monitoring, stimulation, and innovative neuromodulation modalities, announced an addition to the company's newest generation of Stimpod neuromuscular transmission monitor - the capability of utilizing either of the two most industry-prominent types of monitoring sensors: AMG and EMG.
  • "We are excited to announce the EMG modality to our Stimpod line of monitors," stated Corlius Birkill, CEO of Xavant Technology.
  • We believe quantitative or objective monitoring of patients who are undergoing neuromuscular block for surgery should be the standard of care.
  • Xavant Technology (Pty) Ltd is a leading manufacturer and developer of neuromuscular monitors, stimulators, and treatment devices for regional anesthesia, general anesthesia, and pain management applications.

General Anaesthesia Drugs Market is expected to grow at a CAGR of ~3% during the forecast period of 2019 to 2029- Future Market Insights

Retrieved on: 
Monday, August 19, 2019

VALLEY COTTAGE, N.Y. , Aug. 19, 2019 (GLOBE NEWSWIRE) -- A new study of Future Market Insights (FMI) indicates that the global general anesthesia drugs market is poised for steady growth in the years ahead.

Key Points: 
  • VALLEY COTTAGE, N.Y. , Aug. 19, 2019 (GLOBE NEWSWIRE) -- A new study of Future Market Insights (FMI) indicates that the global general anesthesia drugs market is poised for steady growth in the years ahead.
  • Today, the general anesthesia drugs market remains driven by increased proportion of elderly patients and rising volume of surgical procedures; FMI analyst forecasts the market to witness 3.5% CAGR during the period, 2019-2029.
  • According to the FMI analyst, worldwide sales of general anesthesia drugs will increase ~3% year-over-year to total ~US$ 4.3 billion in 2019, up from US$ 4.17 billion in 2018.
  • Preview Analysis Global General Anesthesia Drugs MarketBy Drug Class Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others (Others Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.

The Worldwide Market for Anesthesia Devices, 2019 to 2023 - Rise in Demand for Disposable Anesthesia Devices

Retrieved on: 
Monday, May 13, 2019

DUBLIN, May 13, 2019 /PRNewswire/ --The "Global Anesthesia Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 13, 2019 /PRNewswire/ --The "Global Anesthesia Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
  • The anaesthesia devices market will register a CAGR of over 6% by 2023.
  • The increasing number of surgeries requiring general anaesthesia is one of the key factors expected to trigger the anaesthesia devices market growth during the forecast period.
  • General anaesthesia is administered to the patients by medical practitioners for inducing unconsciousness during surgery and for post-surgery pain management.

Global Anesthesia Devices Market Forecasts 2019-2023 by Product & Geography - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 9, 2019

The "Global Anesthesia Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Anesthesia Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
  • The anaesthesia devices market will register a CAGR of over 6% by 2023.
  • The increasing number of surgeries requiring general anaesthesia is one of the key factors expected to trigger the anaesthesia devices market growth during the forecast period.
  • Vendors in the market are increasingly focusing on adopting marketing strategies to increase their market penetration.

Visiongain Report Offers Transformative Insights on the $11.8bn Anaesthesia Drugs Market

Retrieved on: 
Wednesday, April 24, 2019

LONDON, April 24, 2019 /PRNewswire/ -- Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others

Key Points: 
  • LONDON, April 24, 2019 /PRNewswire/ -- Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others
    The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024.
  • The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.
  • The 241-page report provides clear detailed insight into the global anaesthesia drugs market.
  • To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-anaesthesia-drugs-market-2019-2...
    Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 forthe market segmented by type:
    This report also provides revenue forecast to 2029 for theselocal anaesthesia drugs:

Visiongain Report Offers Transformative Insights on the $11.8bn Anaesthesia Drugs Market

Retrieved on: 
Wednesday, April 24, 2019

LONDON, April 24, 2019 /PRNewswire/ -- Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others

Key Points: 
  • LONDON, April 24, 2019 /PRNewswire/ -- Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others
    The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024.
  • The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.
  • The 241-page report provides clear detailed insight into the global anaesthesia drugs market.
  • To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-anaesthesia-drugs-market-2019-2...
    Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 forthe market segmented by type:
    This report also provides revenue forecast to 2029 for theselocal anaesthesia drugs: